Elizabeth Myers, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 81 Warwick Tpke, Hewitt, NJ 07421 Phone: 973-506-6645 |
Ms. Lynda Ruth Fabbo, MSW, LCSW, CHT Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1954 Clinton Rd, Hewitt, NJ 07421 Phone: 201-341-4200 Fax: 201-528-5331 |
Mrs. Christine Leonides Barton, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 93 Lake Shore Dr, Hewitt, NJ 07421 Phone: 973-718-4344 Fax: 973-718-4344 |
Marie A. Strada, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 81 Warwick Tpke, Hewitt, NJ 07421 Phone: 973-506-6645 |
News Archive
The first clinical study to document risk of acquiring herpes simplex virus type 1 infection based on sexual activity has linked oral sex and vaginal intercourse with a demonstrably higher rate of infection, particularly in young women, researchers from the University of Pittsburgh report in the February issue of Sexually Transmitted Diseases, the journal of the American Sexually Transmitted Diseases Association.
Nearly 26 million Americans have diabetes, costing an economically devastating $245 billion per year in medical costs. Projections suggest one in three Americans will have diabetes in 2050 if present trends continue.
Proteolix, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to carfilzomib, a selective blocker of proteasome activity for the treatment of multiple myeloma.
In a randomized controlled trial of 134 mildly stressed, middle-aged to older adults, participants who were assigned to a six-week mindfulness-meditation training program experienced significantly reduced negative affect variability—which refers to subjective distress and includes a range of mood states such as worry, anxiety, anger, self-criticism, and life dissatisfaction—compared with participants assigned to a waitlist control.
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first machine learning-based Coronavirus Disease 2019 (COVID-19) non-diagnostic screening device that identifies certain biomarkers that are indicative of some types of conditions, such as hypercoagulation (a condition causing blood to clot more easily than normal).
› Verified 1 days ago